DE3050999A1 - - Google Patents

Info

Publication number
DE3050999A1
DE3050999A1 DE19803050999 DE3050999A DE3050999A1 DE 3050999 A1 DE3050999 A1 DE 3050999A1 DE 19803050999 DE19803050999 DE 19803050999 DE 3050999 A DE3050999 A DE 3050999A DE 3050999 A1 DE3050999 A1 DE 3050999A1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803050999
Other languages
German (de)
Other versions
DE3050999C2 (de
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3050999(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of DE3050999A1 publication Critical patent/DE3050999A1/de
Application granted granted Critical
Publication of DE3050999C2 publication Critical patent/DE3050999C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3050999A 1979-03-10 1980-03-10 Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten Expired DE3050999C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
DE3050999A1 true DE3050999A1 (pl) 1985-08-14
DE3050999C2 DE3050999C2 (de) 1986-08-14

Family

ID=26270867

Family Applications (3)

Application Number Title Priority Date Filing Date
DE3009071A Expired DE3009071C2 (de) 1979-03-10 1980-03-10 2-Isopropylamino-hydroxypyrimidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3050999A Expired DE3050999C2 (de) 1979-03-10 1980-03-10 Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten
DE19803016752 Granted DE3016752A1 (de) 1979-03-10 1980-04-30 Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3009071A Expired DE3009071C2 (de) 1979-03-10 1980-03-10 2-Isopropylamino-hydroxypyrimidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19803016752 Granted DE3016752A1 (de) 1979-03-10 1980-04-30 Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten

Country Status (24)

Country Link
JP (1) JPS55122768A (pl)
AR (1) AR222691A1 (pl)
AU (1) AU533547B2 (pl)
BE (1) BE881752A (pl)
CA (1) CA1132561A (pl)
CH (1) CH644368A5 (pl)
DE (3) DE3009071C2 (pl)
EG (1) EG14282A (pl)
FI (1) FI66357C (pl)
FR (2) FR2451191A1 (pl)
GB (1) GB2045756B (pl)
HK (1) HK55383A (pl)
IE (1) IE49547B1 (pl)
IN (1) IN153791B (pl)
LU (1) LU82185A1 (pl)
MX (1) MX6218E (pl)
MY (1) MY8400200A (pl)
NL (1) NL184833C (pl)
NO (1) NO154054C (pl)
NZ (1) NZ192927A (pl)
OA (1) OA06484A (pl)
PT (1) PT70882A (pl)
SE (1) SE435180B (pl)
SG (1) SG22683G (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
IE49547B1 (en) 1985-10-30
DE3009071A1 (de) 1980-09-11
SE435180B (sv) 1984-09-10
DE3009071C2 (de) 1985-11-14
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
MY8400200A (en) 1984-12-31
IN153791B (pl) 1984-08-18
FR2451370B1 (pl) 1983-05-13
NO154054B (no) 1986-04-01
NL184833C (nl) 1989-11-16
AR222691A1 (es) 1981-06-15
NL184468B (nl) 1989-03-01
JPS6126996B2 (pl) 1986-06-23
MX6218E (es) 1984-12-21
FR2451191A1 (fr) 1980-10-10
SE8001812L (sv) 1980-09-11
NZ192927A (en) 1981-07-13
NL184833B (nl) 1989-06-16
SG22683G (en) 1983-12-16
NO154054C (no) 1986-07-09
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
LU82185A1 (fr) 1980-06-06
DE3050999C2 (de) 1986-08-14
DE3016752C2 (pl) 1987-06-25
HK55383A (en) 1983-11-25
NL8001289A (nl) 1980-09-12
IE800477L (en) 1980-09-10
FR2451370A1 (fr) 1980-10-10
FR2451191B1 (pl) 1983-04-29
NO800664L (no) 1980-09-11
GB2045756A (en) 1980-11-05
FI66357C (fi) 1984-10-10
CA1132561A (en) 1982-09-28
PT70882A (en) 1980-03-01
EG14282A (en) 1983-09-30
DE3016752A1 (de) 1980-12-04
FI66357B (fi) 1984-06-29
AU533547B2 (en) 1983-12-01
OA06484A (fr) 1981-07-31
BE881752A (fr) 1980-05-30
FI800566A (fi) 1980-09-11

Similar Documents

Publication Publication Date Title
FR2447856B1 (pl)
FR2448661B3 (pl)
FR2446719B1 (pl)
BR8002583A (pl)
BR8006808A (pl)
FR2448504B1 (pl)
FR2447869B1 (pl)
FR2451370B1 (pl)
FR2445962B1 (pl)
FR2448396B1 (pl)
FR2449313B1 (pl)
FR2446459B3 (pl)
FR2429181B1 (pl)
FR2448974B1 (pl)
FR2448323B1 (pl)
FR2450027B1 (pl)
AU78569S (pl)
AU79918S (pl)
AU79557S (pl)
AU77763S (pl)
AU79200S (pl)
AU78270S (pl)
AU79558S (pl)
AU79559S (pl)
AU78391S (pl)

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 3009071

8181 Inventor (new situation)

Free format text: ESANU, ANDRE, PARIS, FR

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 3009071

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee